Remipharma MB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 57,085 |
| - |
| 27,656 |
| 26,261 |
| - |
| 99.81 |
| 46.00 |
| 25,550 |
| 11,717 |
| 444 |
| 36,823 |
| 0.44 |
| 0.46 |
| - |
| - |
| 48.45 |
| 27,657 |
| 2024 |
|---|
| 57,620 |
| - |
| 37,528 |
| 35,991 |
| - |
| 93.58 |
| 62.46 |
| 61,539 |
| 5,058 |
| 1,531 |
| 65,066 |
| 1.04 |
| 0.08 |
| - |
| - |
| 65.12 |
| 37,524 |
| 2025 |
|---|
| 66,440 |
| - |
| 31,866 |
| 30,390 |
| - |
| 69.30 |
| 45.74 |
| 50,229 |
| 4,351 |
| 31,691 |
| 22,889 |
| 0.28 |
| 0.09 |
| - |
| - |
| 48.25 |
| 32,060 |
| 2025 |
|---|
| 66,440 |
| - |
| 31,866 |
| 30,390 |
| - |
| 69.30 |
| 45.74 |
| 50,229 |
| 4,351 |
| 31,691 |
| 22,889 |
| 0.28 |
| 0.09 |
| - |
| - |
| 48.25 |
| 32,060 |
Turnover (€)
2025
Turnover (€)
66,440 €15 % *
Sales per employee (€)
-Profit before tax (€)
31,866 €-15 % *
Net Profit (€)
30,390 €-16 % *
Profit per employee (€)
-Total profitability (%)
69.30 %-25.95 % *
Net profitability (%)
45.74 %-26.77 % *
Equity (€)
50,229 €-18 % *
Amounts Payable And Liabilities (€)
4,351 €-14 % *
Non-current Assets (€)
31,691 €1,970 % *
CurrentAssets (€)
22,889 €-65 % *
Working capital requirement
0.28 -73.08 % *
Debt-to-equity ratio
0.09 12.50 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
48.25 %-25.91 % *
EBIT (€)
32,060 €-15 % *
